News for hackers. Stuff that matters.

A comment on Biohackers take aim at big pharma’s stranglehold on insulin. Parent comment

Re:Biohackers take aim at big pharma’s stranglehold on insulin by sithlord on Monday June 28, 2021 @04:05PM (#27667177)
they "renew" by "improving" their existing product enough to make it obsolete, and to get a new patent. Per the article below this has been happening since 1923

https://www.hopkinsmedicine.org/news/media/releases/why_peop...

[ Parent | on HN ]
Re:Biohackers take aim at big pharma’s stranglehold on insulin by lotsofpulp on Monday June 28, 2021 @05:28PM (#27668404)
That is better described as a new patent. The product for the patent that expired is expired, and can be made by others.
[ Parent | on HN ]